Extension of mepolizumab injection intervals as potential of saving costs in well controlled patients with severe eosinophilic asthma

HIGHLIGHTS

• who: Georg Bu00f6lke MD from the Institute of Allergology, Charitu00e9 u2013 Universitu00e4tsmedizin Berlin, Corporate Berlin, Germany have published the research work: Extension of mepolizumab injection intervals as potential of saving costs in well controlled patients with severe eosinophilic asthma, in the Journal: (JOURNAL)
• what: This study evaluated the possibility of extending the dosage of in those patients with eosinophilic after being well controlled. This study investigates the effects of interval extension of mepolizumab on asthma symptoms in patients achieving good disease control after initiation of anti-IL-5 therapy.
• how: Both formulas shared . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.